Professor Avan Aihie Sayer, Newcastle University, UK

Professor Avan Aihie Sayer is William Leech Professor of Geriatric Medicine at Newcastle University, Honorary Consultant in Older People’s Medicine at Newcastle Hospitals and Director of the National Institute for Health and Care Research (NHIR) Newcastle Biomedical Research Centre. She has recently been awarded a second term as an NIHR Senior Investigator and is recognised for her world-leading research on ageing, sarcopenia and multimorbidity where the focus is on translating epidemiological and biological insights into improved recognition, intervention and prevention across the life course. She is passionate about bringing through the next generation of researchers to be leaders in this exciting field of translational ageing research.

 She tweets @AvanSayer

Professor Rachel Cooper, Newcastle University, UK 

Rachel Cooper is McArdle Chair in Ageing and Professor of Translational Epidemiology at Newcastle University, UK. For over 15 years Rachel has been applying a life course epidemiological approach to the study of a range of age-related health outcomes, including sarcopenia, with the aim of identifying opportunities across life to the support the development and maintenance of key aspects of health and wellbeing as people age. The ultimate goal of this research is to improve people’s chances of living healthier, active lives for longer and to reduce lifetime inequalities in these chances. Rachel promotes interdisciplinary translational research on ageing through her roles as co-lead for Interdisciplinary Research in the NIHR Newcastle Biomedical Research Centre and as co-lead of the UKRI (BBSRC-MRC) funded ART (Ageing Research Translation) of Healthy Ageing Network.

Professor Alfonso Cruz-Jentoft, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain

Alfonso J. Cruz-Jentoft (MD, PhD) is a specialist in Geriatric Medicine. He is currently Chair of the Geriatric Department at the Hospital Universitario Ramón y Cajal in Madrid, and Professor of Geriatrics at the Universidad Europea de Madrid, Spain. He also chairs the Spanish National Board of Geriatrics and is corresponding member of the Royal National Academy of Medicine of Spain.

Founder and Past President of the European Geriatric Medicine Society (EuGMS), he is currently Editor-in-Chief of European Geriatric Medicine, the official journal of this society and coordinates the European Working Group on Sarcopenia in Older People (EWGSOP) and the Global Leadership Initiative in Sarcopenia (GLIS). Member of the WHO Clinical Consortium on Healthy Ageing, he represents Spain in the Board of the International Association of Gerontology and Geriatrics (IAGG) and serves in the Editorial Board of most major geriatric medicine journals (Age Ageing, J Am Geriatr Soc, JAMDA, JNHA, Aging Clin Exp Res).

Professor Robin Daly, Deakin University, Australia 

Professor Robin Daly, PhD FSMF FASBMR, holds the position of Chair in Exercise and Ageing and is Head of the Musculoskeletal Health and Mobility group within the Institute for Physical Activity and Nutrition at Deakin University. He has over 25 years of experience in conducting clinical, translational and implementation trials to understand how exercise and nutritional approaches can prevent and manage diseases including sarcopenia, osteoporosis, falls and fractures, type 2 diabetes, certain types of cancer and cognitive related disorders. His recent research has focused on the role of digital technologies as a model of healthcare service delivery to manage chronic conditions in older adults. He has published (co-edited) 3 books and >235 peer-reviewed articles and been awarded >$21M is research funding. His work has led to the implementation of evidence‐based, community exercise programs and commercial nutritional products for musculoskeletal health and type 2 diabetes. He is a Past President of the Australian and New Zealand Society for Sarcopenia and Frailty Research, a member of the medical and scientific advisory committee of Healthy Bones Australia, a council member of the International Federation of Musculoskeletal Research Societies (IFMRS) and a Fellow of the American Society for Bone and Mineral Research (ASBMR).

Dr Marie-Josiane Ebode-Ntsama, University of Yaounde, Cameroon

Dr Marie-Josiane Ebode-Ntsama works as an Internist-Geriatrician in the acute geriatric unit of the Yaounde Central Hospital. She is a senior lecturer of Geriatrics at the Faculty of Medicine and Biomedical Sciences of the University of Yaounde I and a co-founder of the Cameroonian Geriatrics and Gerontology Society. She works on several studies in order to understand the course of ageing in sub-Saharan Africa where geriatrics-dedicated health services and policies on ageing are still scarce. Her current research focuses on sarcopenia, frailty and how to improve their detection and management taking into account local available resources. She is also interested on the identification of specific interventions in order to establish an age-friendly model of care in resource-limited settings.

She tweets at @mj_ebodentsama

Professor Miranda Grounds, University of Western Australia, Australia 

For over 40 years the research of Professor Miranda Grounds based at the University of Western Australia has focussed on skeletal muscle biology, using mainly in vivo mouse models to investigate factors controlling the post-natal growth, muscle mass maintenance, damage and regeneration of normal and diseased muscles including age-related loss of muscle mass and function (sarcopenia) and muscular dystrophies. This research encompasses myogenesis, stem cells, growth factors, transplantation, inflammation, oxidative stress and the extracellular matrix, with potential applications to tissue engineering, muscular dystrophies and sarcopenia. A major focus is to strengthen pre-clinical research studies, in order to accelerate efficient development of clinical therapies, working in close collaboration with the international TreatNMD network. 

 Dr Christopher Hurst, Newcastle University, UK 

Chris is a Research Associate within the AGE research group at Newcastle University and a British Association of Sport and Exercise Sciences (BASES) accredited Sport and Exercise Scientist. The early part of his career was focused on improving sports performance across a range of athletic populations before transitioning to apply these principles and experiences with older people during his PhD.

Chris currently works across a range of studies aiming to understand more about the determinants and mechanisms underpinning the development of sarcopenia (the age associated decline in muscle mass and function). Alongside this, Chris is interested in optimising methods for accurately quantifying and assessing muscle mass and physical performance in older people.

The other major strand of Chris’ work is focused on maximising the potential of exercise, particularly resistance exercise, for the prevention and treatment of sarcopenia in older people, particularly in those living with frailty and multiple long-term conditions.

He tweets at @chrishurst99

 ‌

Dr. Silke Hüttner, Rejuvenate Biomed, Belgium 

Dr. Silke Hüttner is Chief Medical Officer of Rejuvenate Biomed and is part of the Management Board. As CMO, she is responsible for medical input in all scientific, strategic and clinical development aspects of the company. She is a physician-scientist with 20 years of experience in the pharmaceutical industry combined with a background in Academic Research and Internal Medicine. Silke previously hold different positions in R&D and Clinical Development at Boehringer Ingelheim (BI) in Germany and in Translational Medicine at Galapagos in Belgium before she joined Rejuvenate Biomed in November 2021.
Silke gained extensive experience in early & late-stage Clinical Development of small molecules and antibodies with focus on different indications in the fields of immunology & inflammation, metabolism, and fibrosis. She further worked in osteoarthritis, kidney diseases, oncology, and some rare diseases.
Silke holds a medical degree from University of Ulm, Germany and earned her doctor’s degree in Immunology at the University of Zurich, Switzerland.

Professor David Scott, Deakin University, Australia 

Associate Professor David Scott (PhD, BHM Hons) is an exercise scientist with expertise in sarcopenia, obesity and osteoporosis, with a particular focus on their impact on disability in older adults. His epidemiological research has challenged the notion that obesity is protective against fractures in older populations, particularly in the setting of ‘sarcopenic obesity’. He currently leads several exercise and nutrition interventions for improving body composition and physical function in older adults with sarcopenia, obesity and osteoporosis, including self-management programs supported by digital health technologies. He is an Australian National Health and Medical Research Council Emerging Leadership Fellow and has published over 200 journal articles and books. He is the Chair of the Australian and New Zealand Society for Sarcopenia and Frailty Research’s Sarcopenia Diagnosis and Management Task Force and a member of the International Osteoporosis Foundation’s Committee of Scientific Advisors.

Professor Miles Witham, Newcastle University, UK

Miles Witham is Professor of Trials for Older People in the NIHR Newcastle Biomedical Research Centre, Newcastle University, where he co-leads the Ageing, Sarcopenia and Multimorbidity Theme. He is also a consultant Geriatrician working in community settings. Professor Witham's research focusses on early and later-phase trials to test interventions targeting sarcopenia and other ageing syndromes including exercise, nutrition and medications. He also has a longstanding interest in improving inclusion of older people in research and in researching ways to improve how we design and deliver trials for older people.

He tweets at @OlderTrialsProf